Coronavirus: Hong Kong confirms three new cases, of which one is untraceable N501Y mutation; nasal spray vaccine on horizon

• HKU team conducting phase-one clinical trials, with product deemed safe so far, and babies as young as six months expected to also be covered once drug hits market
• Fully vaccinated individuals will only need one dose of inhaled version, while the unvaccinated will require two doses